ZARAGOZA SÁNCHEZ, CARLOS,GÓMEZ PARRIZAS, MÓNICA,LAVÍN PLAZA, BEGOÑA,TARÍN CEREZO, CARLOS
申请号：
EP11845312
公开号：
EP2668960A4
申请日:
2011.12.01
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The present invention relates to the use of an EMMPRIN inhibitor for preventing and/or treating cardiac damage arising after an ischemic process followed by reperfusion. The authors of the present invention have observed that EMMPRIN expression increases in subjects who have suffered ischemia/reperfusion, ascertaining that an EMMPRIN inhibitor is capable of reducing the cardiac damage caused after ischemia followed by reperfusion, both in vitro and in vivo .
